Reaction

Aortic Dilatation reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,077 reports · 38 co-occurring drugs

As of the last recalculation, Aortic Dilatation appears in 1,077 FAERS reports alongside 38 co-occurring drug terms. The strongest observed disproportionality signal is AMPHOTERICIN B (PRR 36.2).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Amphotericin B	23	36.2	36.3
Torsemide	54	33.1	33.2
Valganciclovir	30	31.6	31.7
Valganciclovir Hydrochloride	30	31.6	31.7
Captopril	15	30.6	30.6
Sodium Bicarbonate	35	30.0	30.1
Sodium Bicarbonate Injection,	35	30.0	30.1
Tamsulosin Hydrochloride	28	27.2	27.2
Candesartan Cilexetil	35	26.6	26.6
Felodipine Extended-Release Tablets	14	24.1	24.1
Felodipine	14	24.1	24.1
Doxazosin Mesylate	39	21.6	21.6
Chlorhexidine Gluconate	10	21.3	21.4
Doxazosin	28	19.8	19.8
Mycophenolic Acid	31	19.2	19.3
Candesartan	34	19.0	19.0
Nebivolol	15	18.4	18.5
Chlorthalidone	10	16.8	16.8
Meclizine Hcl 12.5Mg	11	15.7	15.8
Meclizine Hcl 25Mg	11	15.7	15.8
Meclizine Hcl 12.5 Mg	11	15.7	15.8
Meclizine Hcl 25 Mg	11	15.7	15.8
Agalsidase Beta	7	14.7	14.7
Valsartan Oral	39	14.4	14.4
Meclizine	12	14.4	14.4
Darbepoetin Alfa	36	13.3	13.3
Terazosin Hydrochloride	6	13.1	13.1
Brivaracetam	6	13.0	13.0
Cannabidiol	15	12.5	12.6
Dorzolamide Hydrochloride And Timolol Maleate	5	12.3	12.3
Clobazam	15	12.0	12.0
Minoxidil Foam 5% (Womens)	20	11.9	11.9
Granisetron Hydrochloride	6	11.2	11.2
Tafamidis	6	9.9	9.9
Fondaparinux Sodium	4	9.6	9.6
Minoxidil	20	8.7	8.8
Pirfenidone	16	7.7	7.7
Sarilumab	6	4.4	4.4

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.